Evidence map›Paper›PMID 19295315›Full record

ArticleTransplantation2009

IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.

Li-Hui Tseng, Barry Storer, Effie Petersdorf, Ming-Tseh Lin, Jason W Chien, Bryan M Grogan, Mari Malkki, Pei-Jer Chen, Lue P Zhao, Paul J Martin and 1 more

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Sibling donor and recipient immune modulation with atorvastatin for the prophylaxis of acute graft-versus-host disease.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2013
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2016
    Article
  9. Review
  10. Genomic studies of GVHD-lessons learned thus far.Bone marrow transplantation · 2013
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Li-Hui TsengFred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Barry Storer
Effie Petersdorf
Ming-Tseh Lin
Jason W Chien
Bryan M Grogan
Mari Malkki
Pei-Jer Chen
Lue P Zhao
Paul J Martin
John A Hansen
Fred Hutch Cancer Center · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
VIRUS-MEDIATED MYELOSUPPRESSIONP01CA018029 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Geoffrey Roger HILL · 1985 to 2026
$128.4M
13TH INTERNATIONAL HISTOCOMPATIBILITY WORKING GROUPU24AI049213 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HANSEN, JOHN ANDREW · 2000 to 2004
$21.3M
TRANSPLANTATION IMMUNOLOGYP01AI033484 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HANSEN, JOHN ANDREW · 1992 to 2013
$13.1M
Whole Genome Association Analysis of Hematopoietic Cell Transplant OutcomeR01HL087690 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HANSEN, JOHN ANDREW · 2006 to 2008
$4.1M
STUDIES ON MARROW GRAFT RESISTANCEP01CA018221 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI STORB, RAINER F. · 1985 to 2001
$2.7M
Genetic Analysis of Airflow Obstruction After Stem Cell TransplantationR01HL088201 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CLARK, JOAN G. · 2008 to 2013
$2.2M
NCI NIH HHS CA15704NCI NIH HHS CA18029NCI NIH HHS CA18221NCI NIH HHS P01 CA018029NCI NIH HHS P30 CA015704NHLBI NIH HHS HL088201NHLBI NIH HHS HL87690NHLBI NIH HHS R01 HL087690NHLBI NIH HHS R01 HL088201NIAID NIH HHS AI33484NIAID NIH HHS AI49213NIAID NIH HHS P01 AI033484NIAID NIH HHS U24 AI049213
6 · The paper itself

Abstract

backgroundResults of a previous study with human leukocyte antigen (HLA)-identical siblings showed individual and synergistic associations of single nucleotide polymorphisms in the promoter region of the recipient's IL10 gene and the donor's IL10 receptor beta (IL-10RB) gene with development of grades III-IV acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation.

methodsIn this study of 936 patients who had unrelated donors, genotypes of single nucleotide polymorphisms in the IL10 gene and the IL-10RB gene were evaluated as correlates with outcomes after transplantation.

resultsWe found no statistically significant associations of polymorphisms at positions -3575, -2763, -1082, and -592 of the IL10 gene or codon 238 of the IL10RB gene with severe acute GVHD, extensive chronic GVHD or nonrelapse mortality after hematopoietic cell transplantation. Among HLA-matched unrelated pairs, the patient's IL10/-592 genotype and donor's IL10RB/c238 genotype showed trends suggesting individual and combined associations with grades III-IV acute GVHD similar to those observed among patients with HLA-identical sibling donors.

conclusionsAlthough genetic variation in IL10 pathway affects risk of acute GVHD and non-relapse mortality in HLA-identical sibling transplants, the current results indicate that genetic variation in the IL10 pathway does not significant affect these outcomes in unrelated donor transplants suggesting that the strength of the alloimmune response in the latter exceeds the anti-inflammatory activity of IL10.

Indexed as

Genetic VariationHematopoietic Stem Cell TransplantationPolymorphism, Single NucleotideFemaleGenotypeGraft vs Host DiseaseHumansInterleukin-10MaleReceptors, Interleukin-10SiblingsTissue DonorsInterleukin-10Receptors, Interleukin-10

Identifiers

PMID19295315
PMCPMC3019105
OpenAlexW2053637314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.